Outcomes of Cardiovascular Magnetic Resonance Imaging in Patients Recently Recovered From Coronavirus Disease 2019 (COVID-19)

Shi, Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan, China., JAMA Cardiol

Guo, Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (COVID-19)., JAMA Cardiol

Inciardi, Cardiac involvement in a patient with coronavirus disease 2019 (COVID-19)., JAMA Cardiol

Li, 2020, SARS-CoV-2 and viral sepsis: observations and hypotheses., Lancet, 395, 1517, 10.1016/S0140-6736(20)30920-X

Ruan, 2020, Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China., Intensive Care Med, 46, 846, 10.1007/s00134-020-05991-x

Chen, 2020, The ACE2 expression in human heart indicates new potential mechanism of heart injury among patients infected with SARS-CoV-2., Cardiovasc Res, 116, 1097, 10.1093/cvr/cvaa078

Varga, 2020, Endothelial cell infection and endotheliitis in COVID-19., Lancet, 395, 1417, 10.1016/S0140-6736(20)30937-5

Xu, 2020, Pathological findings of COVID-19 associated with acute respiratory distress syndrome., Lancet Respir Med, 8, 420, 10.1016/S2213-2600(20)30076-X

Wei, 2020, Glucocorticoid and immunoglobulin to treat viral fulminant myocarditis., Eur Heart J, 41, 2122, 10.1093/eurheartj/ehaa357

Huang, Cardiac involvement in recovered COVID-19 patients identified by magnetic resonance imaging., JACC Cardiovasc Imaging

Harris, 2009, Research electronic data capture (REDCap)—a metadata-driven methodology and workflow process for providing translational research informatics support., J Biomed Inform, 42, 377, 10.1016/j.jbi.2008.08.010

Giannitsis, 2010, Analytical validation of a high-sensitivity cardiac troponin T assay., Clin Chem, 56, 254, 10.1373/clinchem.2009.132654

Fernández-Jiménez, 2015, Fast T2 gradient-spin-echo (T2-GraSE) mapping for myocardial edema quantification: first in vivo validation in a porcine model of ischemia/reperfusion., J Cardiovasc Magn Reson, 17, 92, 10.1186/s12968-015-0199-9

Giri, 2009, T2 quantification for improved detection of myocardial edema., J Cardiovasc Magn Reson, 11, 56, 10.1186/1532-429X-11-56

Verhaert, 2011, Direct T2 quantification of myocardial edema in acute ischemic injury., JACC Cardiovasc Imaging, 4, 269, 10.1016/j.jcmg.2010.09.023

Puntmann, 2018, Society for Cardiovascular Magnetic Resonance (SCMR) expert consensus for CMR imaging endpoints in clinical research: part I—analytical validation and clinical qualification., J Cardiovasc Magn Reson, 20, 67, 10.1186/s12968-018-0484-5

Rogers, 2013, Standardization of T1 measurements with MOLLI in differentiation between health and disease—the ConSept study., J Cardiovasc Magn Reson, 15, 78, 10.1186/1532-429X-15-78

Schulz-Menger, 2013, Standardized image interpretation and post processing in cardiovascular magnetic resonance: Society for Cardiovascular Magnetic Resonance (SCMR) board of trustees task force on standardized post processing., J Cardiovasc Magn Reson, 15, 35, 10.1186/1532-429X-15-35

Dabir, 2014, Reference values for healthy human myocardium using a T1 mapping methodology: results from the International T1 Multicenter cardiovascular magnetic resonance study., J Cardiovasc Magn Reson, 16, 69, 10.1186/s12968-014-0069-x

Puntmann, 2014, 130 Reproducibility of T1 and T2 mapping in health and disease, and assessment of T2 variability across the normal myocardium., Heart, 100, A76, 10.1136/heartjnl-2014-306118.130

Puntmann, 2018, Native T1 and ECV of noninfarcted myocardium and outcome in patients with coronary artery disease., J Am Coll Cardiol, 71, 766, 10.1016/j.jacc.2017.12.020

Puntmann, 2016, T1-mapping and outcome in nonischemic cardiomyopathy: all-cause mortality and heart failure., JACC Cardiovasc Imaging, 9, 40, 10.1016/j.jcmg.2015.12.001

Gravinay, CMR and serology to diagnose COVID-19 infection with primary cardiac involvement., Eur Heart J Cardiovasc Imaging

Luetkens, 2020, Diffuse myocardial inflammation in COVID-19 associated myocarditis detected by multiparametric cardiac magnetic resonance imaging., Circ Cardiovasc Imaging, 13, 10.1161/CIRCIMAGING.120.010897

Caforio, 2013, Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases., Eur Heart J, 34, 2636, 10.1093/eurheartj/eht210

Schumm, 2014, Cardiovascular magnetic resonance risk stratification in patients with clinically suspected myocarditis., J Cardiovasc Magn Reson, 16, 14, 10.1186/1532-429X-16-14

Kindermann, 2008, Predictors of outcome in patients with suspected myocarditis., Circulation, 118, 639, 10.1161/CIRCULATIONAHA.108.769489

Gulati, 2013, Association of fibrosis with mortality and sudden cardiac death in patients with nonischemic dilated cardiomyopathy., JAMA, 309, 896, 10.1001/jama.2013.1363

Grün, 2012, Long-term follow-up of biopsy-proven viral myocarditis: predictors of mortality and incomplete recovery., J Am Coll Cardiol, 59, 1604, 10.1016/j.jacc.2012.01.007

Winau, 2018, High-sensitive troponin is associated with subclinical imaging biosignature of inflammatory cardiovascular involvement in systemic lupus erythematosus., Ann Rheum Dis, 77, 1590, 10.1136/annrheumdis-2018-213661

Improving Cardiovascular Risk Stratification Using T1 Mapping in General Population (IMPReSSION). ClinicalTrials.gov identifier: NCT04444128. Updated June 23, 2020. Accessed July 6, 2020. https://clinicaltrials.gov/ct2/show/NCT04444128

International T1 Multicenter Outcome Study (T1Outcome-DE). ClinicalTrials.gov identifier: NCT03749343. Updated November 21, 2018. Accessed July 6, 2020. https://clinicaltrials.gov/ct2/show/NCT03749343